$0.58
▼ -0.1% Today
as of Aug 5, 16:49 ET
Last 30 days
Recent Press Releases & News
Galmed Pharmaceuticals Develops Oral Film Version of Parkinson's Treatment
Galmed Announces Breakthrough Development of Dispersible Film Delivery (ODF), Brain Penetrating formulation of its SCD1 inhibitor Aramchol for Parkinson's Disease, Targeting $6 Billion Market
Galmed Develops Cardiac-Targeted Aramchol Formulation to Expand Cardiovascular Pipeline (NASDAQ:GLMD)
Overview
52-week range
$0.41
$2.34
9% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
+2.9%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu Aug 28, 2025 | Jun/2025 | $0.63 | — | — | — | — | earnings |
| Thu May 22, 2025 | Mar/2025 | $-0.62 | — | — | — | +2.9% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 27, 2026 | Jun/2026 | OTHER | — | $0.63 |
Implied volatility — last 90 days
No IV snapshots yet for GLMD.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.